# US 6,730,797 B2 · Process for producing crystalline atorvastatin calcium

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,797 B2
- Document ID: US6730797B2
- Status: Granted
- Kind: B2
- Application number: 10/637,886
- Filed: 2003-08-08
- Published: 2004-02-05
- Granted: 2004-05-04
- Earliest claimed: 1999-12-17
- Assignees: Pfizer Science and Technology Ireland Limited
- Inventors: John O'Connell; William Tully; Evelyn Madigan
- Web page: https://patentgrep.com/patent/US6730797B2

## CPC

- C07D 207/34: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A factory scale process for producing crystalline atorvastatin calcium includes the step of drying the isolated product in a vacuum pan dryer. The vacuum pan dryer has an agitator which is continuously rotated at a speed of approximately 1 rpm. High quality material is routinely and consistently produced with reduced cycle time.

## Claims

### Claim 1

A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt comprising the steps of:
(a) reacting a mixture of atorvastatin lactone, methanol, and methyl tert-butyl ether with sodium hydroxide to form the ring-opened sodium salt;
(b) forming a product rich aqueous layer and an organic layer comprising methyl tert-butyl ether containing impurities;
(c) removing the organic layer comprising methyl tert-butyl ether containing impurities;
(d) extracting the product rich aqueous layer with methyl tert-butyl ether;
(e) adding an extra charge of methyl tert-butyl ether to a vessel containing the product rich aqueous layer in an amount of at least 1% w/v of the contents of the vessel;
(f) sealing the reaction vessel;
(g) heating the contents of the sealed reaction vessel to 47° C. to 57° C. in the presence of the extra charge of methyl tert-butyl ether which saturates the crystallization matrix on heating;
(h) adding calcium acetate hemihydrate to the sealed reaction vessel and shortly after commencement of the calcium acetate addition the transfer is stopped and the reaction mixture is seeded with crystalline atorvastatin calcium to form atorvastatin trihydrate hemi calcium salt;
(i) providing a vacuum pan dryer having an agitator; and
(j) drying the isolated product in a vacuum pan dryer whilst continuously rotating the agitator at a speed of from 0.5 rpm to 2 rpm.

### Claim 2 (depends on 1)

The process as claimed in claim 1 comprising continuously rotating the agitator at a speed of approximately 1 rpm.

### Claim 3 (depends on 1)

The process as claimed in claim 1 comprising maintaining vacuum in the pan dryer at a pressure of from −0.80 to −0.99 bar.

### Claim 4 (depends on 2)

The process as claimed in claim 2 comprising maintaining vacuum in the pan dryer at a pressure of from −0.80 to −0.99 bar.

### Claim 5 (depends on 1)

The process as claimed in claim 1 comprising drying the isolated product over a period of from 1 to 4 days.

### Claim 6 (depends on 2)

The process as claimed in claim 2 comprising drying the isolated product over a period of from 1 to 4 days.

### Claim 7 (depends on 1)

The process as claimed in claim 1 comprising drying the isolated product over a period of from 1 to 2 days.

### Claim 8 (depends on 2)

The process as claimed in claim 2 comprising drying the isolated product over a period of from 1 to 2 days.
